BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27351768)

  • 1. Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North Carolina.
    Freeman AT; Meyer AM; Smitherman AB; Zhou L; Basch EM; Shea TC; Wood WA
    Cancer; 2016 Oct; 122(19):3041-50. PubMed ID: 27351768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
    Meyers J; Yu Y; Kaye JA; Davis KL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
    Ho G; Wun T; Muffly L; Li Q; Brunson A; Rosenberg AS; Jonas BA; Keegan THM
    Cancer; 2018 May; 124(9):1938-1945. PubMed ID: 29451695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
    Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
    [No Abstract]   [Full Text] [Related]  

  • 5. Early mortality and overall survival of acute myeloid leukemia based on facility type.
    Bhatt VR; Shostrom V; Giri S; Gundabolu K; Monirul Islam KM; Appelbaum FR; Maness LJ
    Am J Hematol; 2017 Aug; 92(8):764-771. PubMed ID: 28437868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.
    Doll KM; Meng K; Gehrig PA; Brewster WR; Meyer AM
    Am J Obstet Gynecol; 2016 Oct; 215(4):447.e1-447.e13. PubMed ID: 27130238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of treatment site in adolescents and young adults with central nervous system tumors.
    Wolfson J; Sun CL; Kang T; Wyatt L; D'Appuzzo M; Bhatia S
    J Natl Cancer Inst; 2014 Aug; 106(8):dju166. PubMed ID: 25178694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States.
    Medeiros BC; Satram-Hoang S; Hurst D; Hoang KQ; Momin F; Reyes C
    Ann Hematol; 2015 Jul; 94(7):1127-38. PubMed ID: 25791241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
    Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia: how the uninsured fare.
    Bradley CJ; Dahman B; Jin Y; Shickle LM; Ginder GD
    Cancer; 2011 Oct; 117(20):4772-8. PubMed ID: 21455994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Alvarez E; Keegan T; Johnston EE; Haile R; Sanders L; Saynina O; Chamberlain LJ
    Cancer; 2017 Jul; 123(13):2516-2523. PubMed ID: 28241089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality.
    Master S; Mansour R; Devarakonda SS; Shi Z; Mills G; Shi R
    Anticancer Res; 2016 Apr; 36(4):1719-27. PubMed ID: 27069151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia.
    Hu X; Fu W; Wang L; Gao L; Lü S; Xi H; Qiu H; Chen L; Chen J; Ni X; Xu X; Zhang W; Yang J; Wang J; Song X
    Oncotarget; 2016 Jan; 7(3):3623-34. PubMed ID: 26497216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.
    Wolfson JA; Sun CL; Wyatt LP; Hurria A; Bhatia S
    Cancer; 2015 Nov; 121(21):3885-93. PubMed ID: 26218755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations.
    Stein EM; Bonifacio G; Latremouille-Viau D; Guerin A; Shi S; Gagnon-Sanschagrin P; Briggs O; Joseph GJ
    J Med Econ; 2018 Jun; 21(6):556-563. PubMed ID: 29304724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Distance From Academic Cancer Center on Overall Survival of Acute Myeloid Leukemia: Retrospective Analysis of Treated Patients.
    Dhakal P; Lyden E; Muir KE; Al-Kadhimi ZS; Maness LJ; Gundabolu K; Bhatt VR
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e685-e690. PubMed ID: 32660903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database.
    Master S; Munker R; Shi Z; Mills G; Shi R
    Anticancer Res; 2016 Sep; 36(9):4915-21. PubMed ID: 27630349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.